Showing results (41-50 of 210) with videos related to

Sort By:
Pageof 21
AJR. American Journal of Roentgenology|August 22, 2009
Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of diseaseMonika N Vogel, Katja Weisel, Olga Maksimovic, et al.
Frontiers in Immunology|June 2, 2022
Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma CellsJulia Hambach, William Fumey, Tobias Stähler, et al.
Leukemia & Lymphoma|October 24, 2019
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trialsKatja Weisel, Istvan Majer, Lucy DeCosta, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple MyelomaShannon Cope, Kabirraaj Toor, Evan Popoff, et al.
Annals of Hematology|March 11, 2009
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myelomaMartin Kropff, Peter Liebisch, Stefan Knop, et al.
Cancers|July 1, 2020
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre AnalysisPanagiotis Karagiannis, Lena Sänger, Winfried Alsdorf, et al.
Leukemia & Lymphoma|March 15, 2022
Carfilzomib 56 mg/m<sup>2</sup> twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparisonKatja Weisel, Ajay K Nooka, Evangelos Terpos, et al.
Leukemia|October 17, 2020
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVORKatja Weisel, Maria-Victoria Mateos, Francesca Gay, et al.
Academic Radiology|March 4, 2017
Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple MyelomaMarius Horger, Hendrick Ditt, Shu Liao, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|December 24, 2025
Systemic bone loss measured by routine CT is associated with increased pain, postural decompensation, and survival in multiple myelomaJulian Kylies, Katja Weisel, Tobias M Ballhause, et al.
Pageof 21